Dynamics of reactive astrocytes fosters tissue regeneration after cuprizone-induced demyelination.
RiboTag
astrocyte
cuprizone
demyelination
multiple sclerosis
remyelination
Journal
Glia
ISSN: 1098-1136
Titre abrégé: Glia
Pays: United States
ID NLM: 8806785
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
revised:
28
06
2023
received:
30
04
2023
accepted:
30
06
2023
medline:
6
9
2023
pubmed:
17
7
2023
entrez:
17
7
2023
Statut:
ppublish
Résumé
Demyelination in the central nervous system (CNS) is a hallmark of many neurodegenerative diseases such as multiple sclerosis (MS) and others. Here, we studied astrocytes during de- and remyelination in the cuprizone mouse model. To this end, we exploited the ribosomal tagging (RiboTag) technology that is based on Cre-mediated cell type-selective HA-tagging of ribosomes. Analyses were performed in the corpus callosum of GFAP-Cre
Substances chimiques
Cuprizone
5N16U7E0AO
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2573-2590Informations de copyright
© 2023 The Authors. GLIA published by Wiley Periodicals LLC.
Références
Bajenaru, M. L., Zhu, Y., Hedrick, N. M., Donahoe, J., Parada, L. F., & Gutmann, D. H. (2002). Astrocyte-specific inactivation of the Neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Molecular and Cellular Biology, 22, 5100-5113.
Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., James, J. A., Salto-Tellez, M., & Hamilton, P. W. (2017). QuPath: Open source software for digital pathology image analysis. Scientific Reports, 7, 16878.
Behrangi, N., Lorenz, P., & Kipp, M. (2021). Oligodendrocyte lineage marker expression in eGFP-GFAP transgenic mice. Journal of Molecular Neuroscience, 71, 2237-2248.
Bénardais, K., Kotsiari, A., Škuljec, J., Koutsoudaki, P. N., Gudi, V., Singh, V., Vulinović, F., Skripuletz, T., & Stangel, M. (2013). Cuprizone [bis(cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes. Neurotoxicity Research, 24, 244-250.
Binder, M. D., Xiao, J., Kemper, D., Ma, G. Z. M., Murray, S. S., & Kilpatrick, T. J. (2011). Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination. PLoS One, 6, e17727.
Browaeys, R., Saelens, W., & Saeys, Y. (2020). NicheNet: Modeling intercellular communication by linking ligands to target genes. Nature Methods, 17, 159-162.
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., Fanek, Z., Liu, L., Chen, Z., Rothstein, J. D., Ransohoff, R. M., Gygi, S. P., Antel, J. P., & Weiner, H. L. (2014). Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nature Neuroscience, 17, 131-143.
Caraci, F., Spampinato, S., Sortino, M. A., Bosco, P., Battaglia, G., Bruno, V., Drago, F., Nicoletti, F., & Copani, A. (2012). Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection. Cell and Tissue Research, 347, 291-301.
Carnero Contentti, E., Rojas, J. I., Criniti, J., Lopez, P. A., Daccach Marques, V., Soto de Castillo, I., Tkachuk, V., Marrodan, M., Correale, J., Farez, M. F., Kim, H. J., Hyun, J.-W., Messina, S., Mariano, R., Rocca, M. A., Cacciaguerra, L., Filippi, M., Palace, J., & Juryńczyk, M. (2022). Towards imaging criteria that best differentiate MS from NMOSD and MOGAD: Large multi-ethnic population and different clinical scenarios. Multiple Sclerosis and Related Disorders, 61, 103778.
Casper, K. B., & McCarthy, K. D. (2006). GFAP-positive progenitor cells produce neurons and oligodendrocytes throughout the CNS. Molecular and Cellular Neurosciences, 31, 676-684.
Chabas, D., Baranzini, S. E., Mitchell, D., Bernard, C. C., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M., Pedotti, R., Heller, R., Oksenberg, J. R., & Steinman, L. (2001). The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science, 294, 1731-1735.
Cross, A., & Riley, C. (2022). Treatment of Multiple Sclerosis. Treatment of Multiple Sclerosis. Continuum (Minneap Minn), 28, 1025-1051.
Castillo-Rodriguez, M. L. A., Gingele, S., Schröder, L.-J., Möllenkamp, T., Stangel, M., Skripuletz, T., & Gudi, V. (2022). Astroglial and oligodendroglial markers in the cuprizone animal model for de- and remyelination. Histochemistry and Cell Biology, 158, 15-38.
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013). STAR: ultrafast universal RNA-seq aligner. Bioinformatics, 29, 15-21.
Elmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., & Green, K. N. (2014). Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron, 82, 380-397.
Franklin, R. J. M., & Ffrench-Constant, C. (2008). Remyelination in the CNS: From biology to therapy. Nature Reviews. Neuroscience, 9, 839-855.
Franklin, R. J. M., & Goldman, S. A. (2015). Glia disease and repair-Remyelination. Cold Spring Harbor Perspectives in Biology, 7, a020594.
Franklin, R. J. M., & Simons, M. (2022). CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities. Neuron, 110, 3549-3565.
Gharagozloo, M., Bannon, R., & Calabresi, P. A. (2022). Breaking the barriers to remyelination in multiple sclerosis. Current Opinion in Pharmacology, 63, 102194.
Gharagozloo, M., Mace, J. W., & Calabresi, P. A. (2022). Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis. Frontiers in Molecular Neuroscience, 15, 995477.
Ghita, L., Spanier, J., Chhatbar, C., Mulenge, F., Pavlou, A., Larsen, P. K., Waltl, I., Lueder, Y., Kohls, M., Jung, K., Best, S. M., & Kalinke, U. (2021). MyD88 signaling by neurons induces chemokines that recruit protective leukocytes to the virus-infected CNS. Science immunology, 6, eabc9165.
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., Samokhvalov, I. M., & Merad, M. (2010). Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science, 330, 841-845.
Gorter, R. P., & Baron, W. (2022). Recent insights into astrocytes as therapeutic targets for demyelinating diseases. Current Opinion in Pharmacology, 65, 102261.
Gudi, V., Gingele, S., Skripuletz, T., & Stangel, M. (2014). Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned. Frontier in Cellular Neuroscience, 8, 73.
Gudi, V., Moharregh-Khiabani, D., Skripuletz, T., Koutsoudaki, P. N., Kotsiari, A., Skuljec, J., Trebst, C., & Stangel, M. (2009). Regional differences between grey and white matter in cuprizone induced demyelination. Brain Research, 1283, 127-138.
Guo, Z., Su, Y., & Lou, H. (2018). GFAP-positive progenitor cell production is concentrated in specific encephalic regions in young adult mice. Neuroscience Bulletin, 34, 769-778.
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zager, M., Hoffman, P., Stoeckius, M., Papalexi, E., Mimitou, E. P., Jain, J., Srivastava, A., Stuart, T., Fleming, L. M., Yeung, B., … Satija, R. (2021). Integrated analysis of multimodal single-cell data. Cell, 184, 3573-3587.e29.
Hou, J., Zhou, Y., Cai, Z., Terekhova, M., Swain, A., Andhey, P. S., Guimaraes, R. M., Ulezko Antonova, A., Qiu, T., Sviben, S., Strout, G., Fitzpatrick, J. A. J., Chen, Y., Gilfillan, S., Kim, D.-H., Van Dyken, S. J., Artyomov, M. N., & Colonna, M. (2023). Transcriptomic atlas and interaction networks of brain cellsin mouse CNS demyelination and remyelination. Cell Reports, 42, 112293. https://www.cell.com/cell-reports/abstract/S2211-1247(23)00304-2
Huang, Y., Happonen, K. E., Burrola, P. G., O'Connor, C., Hah, N., Huang, L., Nimmerjahn, A., & Lemke, G. (2021). Microglia use TAM receptors to detect and engulf amyloid beta plaques. Nature Immunology, 22, 586-594.
Hur, E. M., Youssef, S., Haws, M. E., Zhang, S. Y., Sobel, R. A., & Steinman, L. (2007). Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nature Immunology, 8, 74-83.
Kaddatz, H., Joost, S., Nedelcu, J., Chrzanowski, U., Schmitz, C., Gingele, S., Gudi, V., Stangel, M., Zhan, J., Santrau, E., Greiner, T., Frenz, J., Müller-Hilke, B., Müller, M., Amor, S., van der Valk, P., & Kipp, M. (2021). Cuprizone-induced demyelination triggers a CD8-pronounced T cell recruitment. Glia, 69, 925-942.
Kariya, Y., Kariya, Y., Saito, T., Nishiyama, S., Honda, T., Tanaka, K., Yoshida, M., Fujihara, K., & Hashimoto, Y. (2015). Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica. BBA Clin, 3, 126-134.
Lampron, A., Larochelle, A., Laflamme, N., Préfontaine, P., Plante, M.-M., Sánchez, M. G., Yong, V. W., Stys, P. K., Tremblay, M.-È., & Rivest, S. (2015). Inefficient clearance of myelin debris by microglia impairs remyelinating processes. The Journal of Experimental Medicine, 212, 481-495.
Lemus, H. N., Warrington, A. E., & Rodriguez, M. (2018). Multiple sclerosis: Mechanisms of disease and strategies for myelin and axonal repair. Neurologic Clinics, 36, 1-11.
Leo, H., & Kipp, M. (2022). Remyelination in multiple sclerosis: Findings in the cuprizone model. International Journal of Molecular Sciences, 23, 16093.
Liu, Y., Namba, T., Liu, J., Suzuki, R., Shioda, S., & Seki, T. (2010). Glial fibrillary acidic protein-expressing neural progenitors give rise to immature neurons via early intermediate progenitors expressing both glial fibrillary acidic protein and neuronal markers in the adult hippocampus. Neuroscience, 166, 241-251.
Lund, H., Pieber, M., Parsa, R., Grommisch, D., Ewing, E., Kular, L., Han, J., Zhu, K., Nijssen, J., Hedlund, E., Needhamsen, M., Ruhrmann, S., Guerreiro-Cacais, A. O., Berglund, R., Forteza, M. J., Ketelhuth, D. F. J., Butovsky, O., Jagodic, M., Zhang, X.-M., & Harris, R. A. (2018). Fatal demyelinating disease is induced by monocyte-derived macrophages in the absence of TGF-β signaling. Nature Immunology, 19, 1-7.
Lutz, P.-E., Tanti, A., Gasecka, A., Barnett-Burns, S., Kim, J. J., Zhou, Y., Chen, G. G., Wakid, M., Shaw, M., Almeida, D., Chay, M.-A., Yang, J., Larivière, V., M'Boutchou, M.-N., van Kempen, L. C., Yerko, V., Prudhomme, J., Davoli, M. A., Vaillancourt, K., … Turecki, G. (2017). Association of a History of child abuse with impaired myelination in the anterior cingulate cortex: Convergent epigenetic, transcriptional, and morphological evidence. The American Journal of Psychiatry, 174, 1185-1194.
Mahad, D. J., Trebst, C., Kivisäkk, P., Staugaitis, S. M., Tucky, B., Wei, T., Lucchinetti, C. F., Lassmann, H., & Ransohoff, R. M. (2004). Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions. Journal of Neuropathology & Experimental Neurology, 63, 262-273.
Mahmood, A., & Miron, V. E. (2022). Microglia as therapeutic targets for central nervous system remyelination. Current Opinion in Pharmacology, 63, 102188.
Matsushima, G. K., & Morell, P. (2001). The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathology, 11, 107-116.
Moore, C. S., Milner, R., Nishiyama, A., Frausto, R. F., Serwanski, D. R., Pagarigan, R. R., Whitton, J. L., Miller, R. H., & Crocker, S. J. (2011). Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination. The Journal of Neuroscience, 31, 6247-6254.
Nicaise, A. M., Johnson, K. M., Willis, C. M., Guzzo, R. M., & Crocker, S. J. (2019). TIMP-1 promotes oligodendrocyte differentiation through receptor-mediated signaling. Molecular Neurobiology, 56, 3380-3392.
Popescu, B. F. G., & Lucchinetti, C. F. (2012). Pathology of demyelinating diseases. Annual Review of Pathology, 7, 185-217.
Ray, A. K., DuBois, J. C., Gruber, R. C., Guzik, H. M., Gulinello, M. E., Perumal, G., Raine, C., Kozakiewicz, L., Williamson, J., & Shafit-Zagardo, B. (2017). Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure. Glia, 65, 2051-2069.
Rojo, R., Raper, A., Ozdemir, D. D., Lefevre, L., Grabert, K., Wollscheid-Lengeling, E., Bradford, B., Caruso, M., Gazova, I., Sánchez, A., Lisowski, Z. M., Alves, J., Molina-Gonzalez, I., Davtyan, H., Lodge, R. J., Glover, J. D., Wallace, R., Munro, D. A. D., David, E., … Pridans, C. (2019). Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populations. Nature Communications, 10, 3215.
Sanz, E., Yang, L., Su, T., Morris, D. R., McKnight, G. S., & Amieux, P. S. (2009). Cell-type-specific isolation of ribosome-associated mRNA from complex tissues. Proceedings of the National Academy of Sciences, 106, 13939-13944.
Schmidt, H., Raasch, J., Merkler, D., Klinker, F., Krauss, S., Brück, W., & Prinz, M. (2009). Type I interferon receptor signalling is induced during demyelination while its function for myelin damage and repair is redundant. Experimental Neurology, 216, 306-311.
Selvaraju, R., Bernasconi, L., Losberger, C., Graber, P., Kadi, L., Avellana-Adalid, V., Picard-Riera, N., Baron Van Evercooren, A., Cirillo, R., Kosco-Vilbois, M., Feger, G., Papoian, R., & Boschert, U. (2004). Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Molecular and Cellular Neurosciences, 25, 707-721.
Sen, M. K., Mahns, D. A., Coorssen, J. R., & Shortland, P. J. (2022). The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis. Glia, 70, 1215-1250.
Skripuletz, T., Hackstette, D., Bauer, K., Gudi, V., Pul, R., Voss, E., Berger, K., Kipp, M., Baumgärtner, W., & Stangel, M. (2013). Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain, 136, 147-167.
Soytürk, H., Karabörk, Ş., & Türkoğlu, Ş. A. (2021). Investigation of IL-17A, IL-17F, IL-34 levels of patient with multiple sclerosis and pseudotumor cerebri. Acta Medica, 52, 114-121.
Srinivasan, R., Lu, T. Y., Chai, H., Xu, J., Huang, B. S., Golshani, P., Coppola, G., & Khakh, B. S. (2016). New transgenic mouse lines for selectively targeting astrocytes and studying calcium signals in astrocyte processes in situ and in vivo. Neuron, 92, 1181-1195.
Stamatellos, V.-P., & Papazisis, G. (2023). Safety and monitoring of the treatment with disease-modifying therapies (DMTs) for multiple sclerosis (MS). Curr Rev Clin Exp Pharmacol, 18, 39-50.
Stangel, M., & Hartung, H.-P. (2002). Remyelinating strategies for the treatment of multiple sclerosis. Progress in Neurobiology, 68, 361-376.
Stangel, M., Kuhlmann, T., Matthews, P. M., & Kilpatrick, T. J. (2017). Achievements and obstacles of remyelinating therapies in multiple sclerosis. Nature Reviews. Neurology, 13, 742-754.
Stanley, E. R., Chen, D. M., & Lin, H. S. (1978). Induction of macrophage production and proliferation by a purified colony stimulating factor. Nature, 274, 168-170.
Stanley, E. R., & Chitu, V. (2014). CSF-1 receptor signaling in myeloid cells. Cold Spring Harbor Perspectives in Biology, 6, a021857.
Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., Jensen, L. J., & von Mering, C. (2019). STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research, 47, D607-D613.
Tien, A. C., Tsai, H. H., Molofsky, A. V., McMahon, M., Foo, L. C., Kaul, A., Dougherty, J. D., Heintz, N., Gutmann, D. H., Barres, B. A., & Rowitch, D. H. (2012). Regulated temporal-spatial astrocyte precursor cell proliferation involves BRAF signalling in mammalian spinal cord. Development, 139, 2477-2487.
Tsiperson, V., Li, X., Schwartz, G. J., Raine, C. S., & Shafit-Zagardo, B. (2010). GAS6 enhances repair following cuprizone-induced demyelination. PLoS One, 5, e15748.
Voskuhl, R. R., Peterson, R. S., Song, B., Ao, Y., Morales, L. B. J., Tiwari-Woodruff, S., & Sofroniew, M. V. (2009). Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. The Journal of Neuroscience, 29, 11511-11522.
Wang, Y., Szretter, K. J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., Barrow, A. D., Diamond, M. S., & Colonna, M. (2012). IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nature Immunology, 13, 753-760.
Wyss-Coray, T., Lin, C., Yan, F., Yu, G. Q., Rohde, M., McConlogue, L., Masliah, E., & Mucke, L. (2001). TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nature Medicine, 7, 612-618.
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012). clusterProfiler: An R package for comparing biological themes among gene clusters. Omics, 16, 284-287.
Zia, S., Hammond, B. P., Zirngibl, M., Sizov, A., Baaklini, C. S., Panda, S. P., Ho, M. F. S., Lee, K. V., Mainali, A., Burr, M. K., Williams, S., Caprariello, A. V., Power, C., Simmen, T., Kerr, B. J., & Plemel, J. R. (2022). Single-cell microglial transcriptomics during demyelination defines a microglial state required for lytic carcass clearance. Molecular Neurodegeneration, 17, 82.